Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults

NCT06444048 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

Enterovirus Infection

Interventions

BIOLOGICAL: EV68-228-N
OTHER: Placebo for EV68-228-N

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]